Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Hold
720
0.1% 121
2026
Q1
$253K Hold
720
0.13% 116
2025
Q4
$236K Hold
720
0.13% 117
2025
Q3
$203K Buy
+720
New +$209K 0.11% 129
2025
Q2
Sell
-750
Closed -$234K 130
2025
Q1
$234K Buy
+750
New +$221K 0.15% 113
2024
Q4
Sell
-702
Closed -$226K 120
2024
Q3
$226K Sell
702
-60
-8% -$19.6K 0.16% 115
2024
Q2
$238K Hold
762
0.18% 109
2024
Q1
$217K Buy
762
+2
+0.3% +$585 0.16% 115
2023
Q4
$219K Hold
760
0.17% 105
2023
Q3
$204K Buy
+760
New +$190K 0.18% 108
2023
Q1
Sell
-810
Closed -$213K 110
2022
Q4
$213K Buy
+810
New +$217K 0.18% 108
2022
Q2
Sell
-844
Closed -$204K 106
2022
Q1
$204K Buy
+844
New +$194K 0.19% 101

Other funds holding AMGN

First Bancorp's AMGN Position: Q2 2026 in Review

First Bancorp held its Amgen (AMGN) position steady in Q2 2026 at 720 shares worth $261K. The position accounts for 0.1% of the portfolio, ranked #121.

First Bancorp first reported a position in AMGN in Q1 2022 and has held it in 12 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • First Bancorp held 720 shares of Amgen worth $261K as of Q2 2026.
  • First Bancorp left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.1% of First Bancorp's portfolio in Q2 2026, its #121 holding.
  • First Bancorp first reported a position in Amgen in Q1 2022 and has held it in 12 quarters since.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on First Bancorp's 13F filing for Q2 2026, filed 11 Aug 2026.